US equities
|
NVDA
$221.30
▼-3.16%
MU
$914.13
▼-4.10%
AAPL
$342.96
▲+0.50%
AMD
$570.82
▼-5.73%
META
$737.54
▼-3.27%
MSFT
$533.69
▼-1.80%
TSLA
$367.16
▼-2.15%
SPCX
$152.16
▼-2.80%
NVDA
$221.30
▼-3.16%
MU
$914.13
▼-4.10%
AAPL
$342.96
▲+0.50%
AMD
$570.82
▼-5.73%
META
$737.54
▼-3.27%
MSFT
$533.69
▼-1.80%
TSLA
$367.16
▼-2.15%
SPCX
$152.16
▼-2.80%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Forma Therapeutics
Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders
September 01, 2022
From
Forma Therapeutics
Via
Business Wire
Tickers
FMTX
Forma Therapeutics Launches formabridge and $1M Grants Program to Support Transition from Pediatric to Adult Care in Sickle Cell Disease
December 09, 2021
From
Forma Therapeutics
Via
Business Wire
Tickers
FMTX
